CVRx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CVRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Aug 26	BuyUS$76,432	Brent Binkowski	Individual	26,223	US$2.91
12 Aug 26	SellUS$3,338	Brent Binkowski	Individual	1,309	US$2.55
02 Mar 26	SellUS$61,349	Kevin Hykes	Individual	7,763	US$7.90
02 Mar 26	SellUS$13,781	Jared Oasheim	Individual	1,744	US$7.90
02 Mar 26	SellUS$10,146	Paul Verrastro	Individual	1,284	US$7.90
02 Mar 26	SellUS$31,326	Robert John	Individual	3,964	US$7.90
02 Mar 26	SellUS$9,973	Philip Adamson	Individual	1,262	US$7.90
20 Feb 26	BuyUS$297,592	Treo Ventures, LLC	Company	46,800	US$6.36
18 Feb 26	BuyUS$2,785	Mudit Jain	Individual	600	US$4.64
26 Nov 25	SellUS$224,040	Johnson & Johnson Innovation - JJDC, Inc.	Company	22,337	US$10.03
24 Nov 25	SellUS$27,132	Johnson & Johnson Innovation - JJDC, Inc.	Company	2,700	US$10.06
12 Nov 25	SellUS$10,000	Johnson & Johnson Innovation - JJDC, Inc.	Company	1,000	US$10.00
07 Nov 25	SellUS$536,310	Johnson & Johnson Innovation - JJDC, Inc.	Company	52,532	US$10.21

Insider Trading Volume

Insider Buying: CVRX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CVRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,740,335	6.53%
General Public	5,470,776	20.5%
VC/PE Firms	7,889,435	29.6%
Institutions	11,541,051	43.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.36% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.1%	Johnson & Johnson Innovation - JJDC, Inc.	4,024,861	US$11.4m	0%	1.21%
7.34%	New Enterprise Associates, Inc.	1,954,440	US$5.6m	-3.54%	0.33%
7.17%	Vensana Capital Management, LLC	1,910,134	US$5.4m	0%	no data
5.49%	Jorey Chernett	1,461,750	US$4.2m	0%	no data
4.67%	BlackRock, Inc.	1,245,459	US$3.5m	21.3%	no data
4.63%	Royal Bank of Canada	1,233,212	US$3.5m	74.4%	no data
4.61%	Gilde Healthcare Partners BV	1,229,022	US$3.5m	0%	3.77%
3.9%	Vanguard Capital Management, LLC	1,039,531	US$3.0m	0.04%	no data
3.78%	GSK Equity Investments, Limited	1,007,583	US$2.9m	0%	0.28%
3.68%	Treo Ventures, LLC	980,183	US$2.8m	0%	no data
3.3%	Silvercrest Asset Management Group LLC	878,109	US$2.5m	53.5%	0.02%
1.65%	Geode Capital Management, LLC	440,786	US$1.3m	3.21%	no data
1.39%	PFM Health Sciences, LP	369,572	US$1.0m	0%	0.09%
1.38%	State Street Investment Management	366,352	US$1.0m	4.51%	no data
0.86%	Renaissance Technologies LLC	230,000	US$653.2k	1,090%	no data
0.84%	UBS Asset Management AG	224,233	US$636.8k	116%	no data
0.77%	Tudor Investment Corporation	205,684	US$584.1k	4.23%	no data
0.54%	Morgan Stanley	142,892	US$405.8k	5.77%	no data
0.52%	Goldman Sachs Asset Management, L.P.	138,646	US$393.8k	43.6%	no data
0.5%	Kestra Advisory Services, LLC	132,400	US$376.0k	176%	no data
0.5%	Two Sigma Investments, LP	132,398	US$376.0k	16%	no data
0.48%	Dimensional Fund Advisors LP	127,971	US$363.4k	143%	no data
0.47%	Northern Trust Global Investments	124,767	US$354.3k	-16.9%	no data
0.4%	Vanguard Portfolio Management, LLC	105,915	US$300.8k	11.7%	no data
0.39%	Cresset Asset Management, LLC	103,849	US$294.9k	-2.35%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/23 23:22
End of Day Share Price	2026/08/21 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CVRx, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
William Plovanic	Canaccord Genuity
Ross Osborn	Cantor Fitzgerald & Co.
Sarah James	Cantor Fitzgerald & Co.